#162212

Anti-rGFAP PAb

Cat. #162212

Anti-rGFAP PAb

Cat. #: 162212

Sub-type: Primary antibody

Unit size: 100 ug

Target: glial fibrillary acidic protein GFAP

Class: Polyclonal

Application: WB ; IP ; IHC

Reactivity: Human

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Roy Quinlan

Institute: University of Durham

Primary Citation: J E Ralton, et al. 1994. J Cell Sci. 107 ( Pt 7):1935-48. PMID: 7983160.

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-rGFAP PAb
  • Alternate name: GFAP
  • Research fields: Array
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: 51kDa, 432 residues
  • Reactivity: Human
  • Application: WB ; IP ; IHC
  • Description: Polyclonal antibodies specific for GFAP, an intermediate filament protein important in chaperone mediate autophagy and cytoskeletal function. This polyclonal antibody will likely detect all splice variants.
  • Immunogen: recombinant human GFAP
  • Isotype: IgG
  • Recommended controls: astrocytoma cytoskeletal extract from U343MG/U373MG or a spinal cord extract

Target Details

  • Target: glial fibrillary acidic protein GFAP
  • Target alternate names: GFAP
  • Molecular weight: 51kDa, 432 residues
  • Target background: GFAP is an intermediate filament that is expressed in astrocytes. Intermediate filaments are a distinct group of cytoskeletal molecules.

Applications

  • Application: WB ; IP ; IHC

Handling

  • Format: Liquid
  • Concentration: 1mg/ml
  • Unit size: 100 ug
  • Storage buffer: Serum plus azide (0.02%)
  • Storage conditions: -80° C
  • Shipping conditions: Dry ice